Apo-Fluoxetine Indications/Uses

Depression: APO-FLUOXETINE (fluoxetine hydrochloride) may be indicated for the symptomatic relief of depressive illness.
Bulimia Nervosa: Fluoxetine hydrochloride has been shown to significantly decrease binge-eating and purging activity when compared with placebo treatment.
Obsessive-Compulsive Disorder: Fluoxetine hydrochloride has been shown to significantly reduce the symptoms of obsessive-compulsive disorder in double blind placebo controlled studies.
The obsessions of compulsions must be experienced as intrusive, markedly distressing, time consuming or interfering significantly with the persons social or occupational function.
The efficacy of fluoxetine hydrochloride in hospitalized patients has not been studied.
The effectiveness of fluoxetine in long-term use (i.e. for more than 5 to 6 weeks in depression, for more than 16 weeks in bulimia nervosa, or for more than 13 weeks in obsessive compulsive disorder), has not been systemically evaluated in controlled trials. Therefore, the physician who elects to use APO-FLUOXETINE for extended periods should periodically re-evaluate the long-term usefulness of the drug of the individual patient.